Stephen J. Schuster, MD, Abramson Cancer Center

Ongoing Issues in CAR T-Cell Therapy and Lymphoma

Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center

July 2nd 2020

Developing CAR T-Cell Trials

Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center

July 2nd 2020

Allogenic CAR T-Cell Therapy in Lymphoma

Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center

July 2nd 2020

CAR T-Cell Therapy’s Future for Lymphoma

Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center

July 2nd 2020

CAR T Cells and Lymphoma Adverse Events

Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center

July 2nd 2020

LBCL Therapy: The Right Therapy

Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center

July 2nd 2020

R/R NHL: Candidate Identification and Referrals

Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center

July 2nd 2020

CAR T-Cell Therapy for Follicular Lymphoma

Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center

July 2nd 2020

ZUMA-2 Trial Overview: Mantle Cell Lymphoma Impact

Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center

July 2nd 2020

LDH and ECOG Performance Tests

Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center

July 2nd 2020

Liso-cel Therapy in R/R Large B-Cell Lymphoma

Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center

July 2nd 2020

The Importance of Antigen Loss in R/R Disease

Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center

July 2nd 2020

R/R Large B-Cell Therapy in Managing Various Lymphomas

Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center

July 2nd 2020

CAR T-Cell Therapy in Managing Various Lymphomas

Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center

July 2nd 2020

Rationale for Further Development of CAR T-Cell therapy

Stephen J. Schuster, MD, Abramson Cancer Center;Caron A. Jacobson, MD, Dana-Farber Cancer Institute;Matthew J. Frigault, MD, Massachusetts General Hospital Cancer Center;David Miklos, MD, Stanford University;Loretta J. Nastoupil, MD, MD Anderson Cancer Center

July 2nd 2020

Dr. Schuster on GO29781 Trial With Mosunetuzumab in NHL

Stephen J. Schuster, MD, Abramson Cancer Center

March 27th 2020

Stephen J. Schuster, MD, director of the Lymphoma Program, director of Translational Research, Robert and Margarita Louis-Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma Clincai Care and Research at University of Pennsylvania, discusses the results of the phase I/Ib dose-escalation GO29781 trial (NCT02500407) with mosunetuzumab in relapsed/refractory non-Hodgkin lymphoma (NHL).

Dr. Schuster on Long-Term Outcomes of Lenalidomide and Rituximab in MCL

Stephen J. Schuster, MD, Abramson Cancer Center

March 8th 2018

Stephen J. Schuster, MD, professor of hematology/oncology at the University of Pennsylvania Abramson Cancer Center, discusses long-term outcomes of lenalidomide (Revlimid) and rituximab (Rituxan) in mantle cell lymphoma (MCL).

Dr. Schuster Dicsusses CAR T-Cell Therapy in DLBCL

Stephen J. Schuster, MD, Abramson Cancer Center

March 1st 2018

Stephen J. Schuster, MD, professor of hematology/oncology at the University of Pennsylvania Abramson Cancer Center, discusses CAR T-cell therapy in diffuse large B-cell lymphoma.

Stephen J. Schuster, MD, Abramson Cancer Center

Articles

Latest Updated Articles

Latest Conference Coverage